Bowel (colorectal) cancer
Study to assess how genetic differences (UGT1A1 gene variation) affect the safety of irinotecan treatment in cancer patients at a tertiary care hospital in South India.
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Sri venkateswara institute of medical sciences and research- SPMCWTirupati, Andhra PradeshDirections ↗
Registry summary (technical)
A prospective observational study to determine the influence of the UGT1A1 gene polymorphism on the safety profile of IRINOTECAN in cancer patients in a tertiary care centre in South India. - IRINOGEN
Sponsor: Dr k Umamaheswara Rao
CTRI/2026/03/106558 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026